
About Shalby Hospitals
Shalby Hospitals is a publicly listed company based in Ahmedabad (India) founded in 1994 by Vikram Shah. Multi-specialty hospital services are delivered through a chain in India. The company has 2,497 employees. Shalby Hospitals has completed 2 acquisitions, including Sanar International Hospitals and Slaney Healthcare. Its chief executive, as recorded, is Ravi Bhandari. Its website shalby.org draws about 36 thousand monthly visits. Its Indian entity Shalby Limited reported revenue of βΉ1,168 Cr. Its focus areas include Hospital Chains and Multispecialty Hospital Chains. Similar companies include Fortis Healthcare, Ujala Cygnus and Narayana Health; 2 of its 3 listed similar companies have raised funding.
Company details
Shalby Hospitals was established in 1994 in Ahmedabad, India, as a chain of multi-specialty facilities. Healthcare services across various specialties are provided by the organization, with operations centered in India. The network focuses on medical treatments and patient care in urban and regional areas. Leadership is held by founder Vikram Shah and CEO Ravi Bhandari, supporting expansion in the healthcare sector.
- Headquarters Ahmedabad, India
- Employees 2,497
- Founders Vikram Shah
- Stage Public
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website shalby.org
- Social LinkedIn X Facebook Instagram
- Legal Name Shalby Ltd.
- Market Cap₹1,317 Cr
SHALBY · NSE
- Share Price₹122.15
+0.21% today
- Revenue₹1,141 Cr
FY 2025-26 · +5.0% YoY
- EBITDA₹145 Cr
Margin 12.7%
- Net Profit₹24.48 Cr
FY 2025-26 · +305.9% YoY
- P/E (TTM)32.8x
P/B 1.3x
- ROE2.2%
ROCE 6.1%
- Debt / Equity0.54
Interest cover 55.0x
- Employee Count2,497
- Investments & AcquisitionsSanar International Hospitals
& 1 more
Associated legal entities of Shalby Hospitals
Shalby Hospitals is associated with 6 registered companies on The Company Check; the primary company is Shalby Limited, a listed company. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Shalby Limited Listed CIN L85110GJ2004PLC044667 | Active | 30 Aug 2004 | Ahmedabad, Gujarat | ₹1,168 Cr | 2,529 | 8 | View details |
| Vrundavan Shalby Hospitals Limited CIN U85110GA1995PLC001851 | Active | 10 May 1995 | Goa, India | ₹3.2 Cr | 2 | 5 | View details |
| Shalby Medtech Limited CIN U33100GJ2020PLC113358 | Active | 03 Apr 2020 | Ahmedabad, Gujarat | ₹81.3 Cr | 11 | 5 | View details |
| Shalby Hospitals Mumbai Private Limited CIN U85100GJ2020PTC118765 | Active | 10 Dec 2020 | Ahmedabad, Gujarat | ₹0.1 Cr | 3 | View details | |
| Shalby International Limited CIN U85100GJ2012PLC071824 | Active | 05 Sep 2012 | Ahmedabad, Gujarat | ₹0.0 Cr | 3 | View details | |
| Slaney Healthcare Private Limited CIN U33125GJ2008PTC052648 | Active | 16 Jan 2008 | Ahmedabad, Gujarat | ₹31.3 Cr | 29 | 4 | View details |
Board of directors of Shalby Limited (Shalby Hospitals)
Shalby Limited is the primary company behind Shalby Hospitals. The boards of the 6 registered companies of Shalby Hospitals currently have 12 directors; the longest-serving is Shyamal Shivkumar Joshi, appointed in 2011. 42 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Shyamal Shivkumar Joshi DIN 00005766 | Director | 12 Aug 2011 | 15 yrs 3 mo | Vrundavan Shalby Hospitals Limited, Shalby Medtech Limited, Shalby Limited |
| Shanay Vikram Shah DIN 02726541 | Director | 10 Oct 2011 | 15 yrs 1 mo | Slaney Healthcare Private Limited, Shalby Hospitals Mumbai Private Limited, Shalby International Limited |
| Ravi Bhandari DIN 06395271 | Director | 21 Nov 2012 | 14 yrs | Vrundavan Shalby Hospitals Limited, Slaney Healthcare Private Limited, Shalby International Limited |
| Darshini Vikram Shah DIN 00013903 | Director | 15 May 2014 | 12 yrs 6 mo | Slaney Healthcare Private Limited |
| Umesh Krishnankutty Menon DIN 00086971 | Director | 20 Dec 2016 | 9 yrs 11 mo | Shalby Limited |
| Tej Ramjidass Malhotra DIN 00122419 | Director | 23 Feb 2017 | 9 yrs 8 mo | Shalby Limited |
| Viral Bhalchandra Shah DIN 02928038 | Managing Director | 15 Sep 2017 | 9 yrs 2 mo | Vrundavan Shalby Hospitals Limited, Slaney Healthcare Private Limited |
| Ashok Bhatia DIN 02090239 | Director | 23 Oct 2017 | 9 yrs | Shalby Limited |
| Sujana Manan Shah DIN 08100410 | Director | 03 Apr 2020 | 6 yrs 7 mo | Shalby Medtech Limited, Shalby Limited |
| Vikram Indrajit Shah DIN 00011653 | Managing Director | 03 Apr 2020 | 6 yrs 7 mo | Shalby Medtech Limited, Shalby Limited, Shalby Hospitals Mumbai Private Limited, Shalby International Limited |
| Tushar Dineshchandra Shah DIN 06739455 | Company Secretary | 07 Sep 2021 | 5 yrs 2 mo | Shalby Medtech Limited |
| Babu Thomas DIN 10669722 | Director | 15 Jun 2024 | 2 yrs 5 mo | Shalby Hospitals Mumbai Private Limited |
People of Shalby Hospitals
42 people are tracked at Shalby Hospitals (12 in leadership, 30 in team); the tracked headcount is 2,497.
| Name | Role | Group |
|---|---|---|
| Founder | Leadership | |
| CEO | Leadership | |
Anith Sankaran | Head Of Supply Chain Management & Operations- Global | Leadership |
Nilesh Soni | Vice President | Leadership |
Amit Nerurkar | Chief Information Officer | Leadership |
Shivam Mahor | Head Of Sales Marketing | Leadership |
Deepak Ananthakrishnan | Chief Business Officer - Global | Leadership |
Amit Pathak | Group Chief Financial Officer | Leadership |
Ajay Kumar Rao | Associate Vice President | Leadership |
| Associate Vice President & Company Secretary | Leadership | |
Siddhartha Pandey | Associate Vice President - Supply Chain | Leadership |
Masila Mani | Associate Vice President - Learning & Development | Business Head Shalby Academy | Leadership |
Shashwat Sood | Sr Manager Corporate Development | Team |
Pradeep Jayswal | Assistant Manager Human Resources | Team |
Gladwin Nayyar | CAO | Team |
Sana Siddique | Patient Relation Officer | Team |
Mohan Rabari | Senior Executive Supply Chain Management | Team |
Kishan Pandya | Purchase Executive | Team |
Madhur Awasthi | Supply Chain Manager | Team |
Mamta Chouhan | Senior Executive | Team |
22 more people are available in the full profile.
Complete people profiles for Shalby Hospitals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Shalby Hospitals
Shalby Hospitals is a publicly listed company on the NSE with ticker symbol SHALBY in India, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date15 Dec 2017
- Listed onBSE: 540797 · NSE: SHALBY
- Listed entityShalby Ltd.
- Exchange sectorHealth services
- ISININE597J01018
- Share price₹133.02 (+0.53% on the day) · 2026-10-14
- Market capitalisation₹1,435 Cr
- Price to earnings36.1
- EPS (diluted, trailing year)₹3.68
- Volume (last session)14,196
Financials of Shalby Hospitals
Exchange-reported figures of Shalby Limited, the listed company behind Shalby Hospitals (NSE: SHALBY).
Financial Highlights
FY 2025-26 Β· ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 1,141 | 1,087 | 934 | 805 | 699 | 431 | 487 |
| Revenue growth | +5.0% | +16.4% | +16.0% | +15.2% | +62.2% | -11.5% | - |
| EBITDA | 145 | 135 | 179 | 138 | 117 | 87.33 | 82.77 |
| EBITDA margin | +12.7% | +12.4% | +19.1% | +17.2% | +16.8% | +20.3% | +17.0% |
| Profit before tax | 60.54 | 55.73 | 128 | 102 | 79.16 | 55.05 | 56.71 |
| Net profit | 24.48 | (11.89) | 79.26 | 66.52 | 56.03 | 43.19 | 27.15 |
| Net profit margin | +2.1% | -1.1% | +8.5% | +8.3% | +8.0% | +10.0% | +5.6% |
| EPS (βΉ) | 3.48 | 0.58 | 7.83 | 6.31 | 5.01 | 3.93 | 2.55 |
| Balance sheet | |||||||
| Total assets | 1,615 | 1,486 | 1,400 | 1,122 | 1,058 | 901 | 879 |
| Net worth | 1,005 | 992 | 1,000 | 928 | 876 | 835 | 799 |
| Total debt | 595 | 476 | 378 | 180 | 155 | 44.03 | 62.21 |
| Cash & bank | 21.94 | 34.86 | 27.23 | 12.29 | 111 | 83.57 | 28.73 |
| Net working capital | 482 | 409 | 299 | 256 | 321 | 182 | 136 |
| Cash flow | |||||||
| Cash from operations | (0.01) | (4.34) | 19.60 | 67.78 | 18.92 | 79.15 | 55.37 |
| Cash from investing | (97.28) | (35.64) | 146 | (61.08) | (60.28) | (51.27) | (30.67) |
| Cash from financing | 84.41 | 47.58 | (151) | (50.00) | 90.46 | (29.86) | (21.50) |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 313 | 331 | 287 | 272 | 285 | 296 | 265 | 276 |
| Revenue growth (YoY) | +9.7% | +11.7% | +8.5% | -1.3% | +6.7% | +6.3% | - | - |
| Other income | 5.04 | 7.41 | 8.08 | 7.23 | 4.48 | 7.01 | 5.32 | 5.42 |
| EBITDA | 41.39 | 41.59 | 29.35 | 30.26 | 41.61 | 41.54 | 20.84 | 33.90 |
| EBITDA margin | +13.2% | +12.6% | +10.2% | +11.1% | +14.6% | +14.0% | +7.9% | +12.3% |
| Depreciation | 18.92 | 18.74 | 18.49 | 17.61 | 17.37 | 16.52 | 16.23 | 16.32 |
| Interest | 11.05 | 10.57 | 9.34 | 10.64 | 9.65 | 9.37 | 10.67 | 10.66 |
| Profit before tax | 16.46 | 19.69 | 9.60 | 9.24 | 19.07 | 22.66 | (0.74) | 12.34 |
| Tax | 8.59 | 9.20 | (8.85) | 7.95 | 11.80 | 14.97 | 11.45 | 15.34 |
| Net profit | 7.87 | 10.49 | 18.45 | 1.29 | 7.27 | 7.69 | (12.19) | (3.00) |
| EPS (βΉ) | 0.73 | 0.98 | 1.72 | 0.12 | 0.68 | 0.71 | (1.13) | (0.28) |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 899 | 869 | 830 | 708 | 647 | 419 | 484 |
| Revenue growth | +3.4% | +4.7% | +17.2% | +9.5% | +54.5% | -13.5% | - |
| EBITDA | 146 | 157 | 179 | 143 | 127 | 87.03 | 82.54 |
| EBITDA margin | +16.2% | +18.1% | +21.6% | +20.2% | +19.6% | +20.8% | +17.1% |
| Profit before tax | 116 | 136 | 158 | 121 | 99.92 | 55.48 | 57.01 |
| Net profit | 108 | 72.56 | 98.77 | 79.61 | 71.95 | 43.34 | 27.53 |
| Net profit margin | +12.0% | +8.4% | +11.9% | +11.2% | +11.1% | +10.4% | +5.7% |
| EPS (βΉ) | 10.50 | 7.80 | 9.67 | 7.53 | 6.46 | 3.97 | 2.59 |
| Balance sheet | |||||||
| Total assets | 1,392 | 1,256 | 1,196 | 1,016 | 970 | 915 | 894 |
| Net worth | 1,247 | 1,134 | 1,062 | 970 | 907 | 850 | 814 |
| Total debt | 131 | 110 | 121 | 34.08 | 41.31 | 44.03 | 62.21 |
| Cash & bank | 13.39 | 21.66 | 9.23 | 3.32 | 104 | 82.97 | 28.71 |
| Net working capital | 178 | 129 | 105 | 82.03 | 250 | 183 | 139 |
| Cash flow | |||||||
| Cash from operations | 91.19 | 149 | 140 | 165 | 101 | 77.24 | 57.09 |
| Cash from investing | (109) | (101) | (206) | (172) | (40.32) | (51.83) | (32.28) |
| Cash from financing | 9.16 | (35.80) | 72.14 | (38.21) | (17.25) | (27.82) | (21.50) |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 245 | 254 | 225 | 214 | 224 | 237 | 207 | 221 |
| Revenue growth (YoY) | +9.5% | +7.2% | +8.6% | -3.2% | +5.5% | +1.7% | - | - |
| Other income | 5.29 | 5.28 | 5.59 | 7.51 | 5.81 | 5.52 | 7.19 | 6.28 |
| Total expenses | 205 | 211 | 194 | 186 | 185 | 190 | 176 | 178 |
| EBITDA | 40.40 | 42.49 | 30.76 | 27.91 | 38.97 | 46.84 | 30.77 | 42.53 |
| EBITDA margin | +16.5% | +16.7% | +13.7% | +13.1% | +17.4% | +19.8% | +14.9% | +19.3% |
| Depreciation | 10.95 | 10.80 | 10.53 | 10.00 | 9.94 | 9.68 | 9.63 | 9.94 |
| Interest | 3.19 | 3.08 | 2.36 | 3.55 | 4.28 | 2.58 | 2.66 | 3.09 |
| Profit before tax | 31.55 | 33.89 | 23.46 | 21.87 | 30.56 | 40.10 | 25.67 | 35.78 |
| Tax | 8.05 | 8.82 | (30.21) | 8.09 | 10.81 | 14.41 | 10.72 | 14.91 |
Financial Statements
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 313 | 331 | 287 | 272 | 285 | 296 | 265 | 276 |
| Revenue growth (YoY) | +9.7% | +11.7% | +8.5% | -1.3% | +6.7% | +6.3% | - | - |
| Other income | 5.04 | 7.41 | 8.08 | 7.23 | 4.48 | 7.01 | 5.32 | 5.42 |
| EBITDA | 41.39 | 41.59 | 29.35 | 30.26 | 41.61 | 41.54 | 20.84 | 33.90 |
| EBITDA margin | +13.2% | +12.6% | +10.2% | +11.1% | +14.6% | +14.0% | +7.9% | +12.3% |
| Depreciation | 18.92 | 18.74 | 18.49 | 17.61 | 17.37 | 16.52 | 16.23 | 16.32 |
| Interest | 11.05 | 10.57 | 9.34 | 10.64 | 9.65 | 9.37 | 10.67 | 10.66 |
| Profit before tax | 16.46 | 19.69 | 9.60 | 9.24 | 19.07 | 22.66 | (0.74) | 12.34 |
| Tax | 8.59 | 9.20 | (8.85) | 7.95 | 11.80 | 14.97 | 11.45 | 15.34 |
| Net profit | 7.87 | 10.49 | 18.45 | 1.29 | 7.27 | 7.69 | (12.19) | (3.00) |
| EPS (βΉ) | 0.73 | 0.98 | 1.72 | 0.12 | 0.68 | 0.71 | (1.13) | (0.28) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 1,141 | 1,087 | 934 | 805 | 699 | 431 | 487 |
| Revenue growth | +5.0% | +16.4% | +16.0% | +15.2% | +62.2% | -11.5% | - |
| Other income | 26.79 | 27.60 | 19.43 | 22.52 | 12.42 | 9.06 | 17.37 |
| Total expenses | 996 | 952 | 755 | 667 | 582 | 344 | 404 |
| Employee cost | 188 | 185 | 155 | 144 | 118 | 56.96 | 65.50 |
| EBITDA | 145 | 135 | 179 | 138 | 117 | 87.33 | 82.77 |
| EBITDA margin | +12.7% | +12.4% | +19.1% | +17.2% | +16.8% | +20.3% | +17.0% |
| Depreciation | 69.99 | 65.76 | 52.24 | 48.09 | 42.87 | 36.80 | 36.02 |
| Interest | 41.33 | 40.84 | 17.62 | 10.56 | 7.53 | 4.54 | 7.41 |
| Profit before tax | 60.54 | 55.73 | 128 | 102 | 79.16 | 55.05 | 56.71 |
| Tax | 25.87 | 53.81 | 44.70 | 34.37 | 25.17 | 12.69 | 29.14 |
| Net profit | 24.48 | (11.89) | 79.26 | 66.52 | 56.03 | 43.19 | 27.15 |
| Net profit margin | +2.1% | -1.1% | +8.5% | +8.3% | +8.0% | +10.0% | +5.6% |
| EPS (βΉ) | 3.48 | 0.58 | 7.83 | 6.31 | 5.01 | 3.93 | 2.55 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 108 | 107 | 107 | 107 | 108 | 108 | 108 |
| Reserves & surplus | 898 | 885 | 893 | 820 | 768 | 727 | 691 |
| Shareholders' funds (net worth) | 1,005 | 992 | 1,000 | 928 | 876 | 835 | 799 |
| Minority interest | 0.46 | 3.14 | 7.41 | (0.07) | (0.14) | 0.02 | 0.05 |
| Secured loans | 540 | 427 | 313 | 142 | 155 | 44.03 | 48.67 |
| Unsecured loans | 54.97 | 49.21 | 64.72 | 38.83 | 0.00 | 0.00 | 13.54 |
| Total debt | 595 | 476 | 378 | 180 | 155 | 44.03 | 62.21 |
| Total liabilities | 1,615 | 1,486 | 1,400 | 1,122 | 1,058 | 901 | 879 |
| Assets | |||||||
| Gross block | 1,482 | 1,329 | 1,285 | 910 | 860 | 804 | 782 |
| Net block | 1,046 | 955 | 966 | 685 | 675 | 660 | 672 |
| Capital work in progress | 18.81 | 21.97 | 15.39 | 10.55 | 5.77 | 7.52 | 6.39 |
| Investments | 62.26 | 94.63 | 80.64 | 146 | 24.70 | 15.63 | 27.99 |
| Inventories | 385 | 324 | 237 | 185 | 121 | 23.05 | 15.22 |
| Sundry debtors | 228 | 175 | 145 | 106 | 101 | 94.69 | 94.86 |
| Cash & bank balances | 21.94 | 34.86 | 27.23 | 12.29 | 111 | 83.57 | 28.73 |
| Loans & advances | 30.33 | 34.05 | 64.56 | 67.47 | 93.60 | 54.35 | 67.04 |
| Total current assets | 666 | 569 | 473 | 372 | 426 | 256 | 206 |
| Total current liabilities | 184 | 160 | 174 | 115 | 105 | 73.21 | 69.72 |
| Net working capital | 482 | 409 | 299 | 256 | 321 | 182 | 136 |
| Total assets | 1,615 | 1,486 | 1,400 | 1,122 | 1,058 | 901 | 879 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 34.79 | 27.18 | 12.24 | 55.55 | 6.48 | 8.46 | 5.26 |
| Net cash from operating activities | (0.01) | (4.34) | 19.60 | 67.78 | 18.92 | 79.15 | 55.37 |
| Net cash from investing activities | (97.28) | (35.64) | 146 | (61.08) | (60.28) | (51.27) | (30.67) |
| Net cash from financing activities | 84.41 | 47.58 | (151) | (50.00) | 90.46 | (29.86) | (21.50) |
| Net change in cash | (12.88) | 7.61 | 14.94 | (43.31) | 49.10 | (1.98) | 3.21 |
| Closing cash | 21.94 | 34.86 | 27.23 | 12.29 | 111 | 83.57 | 28.73 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +5.0% | +16.4% | +16.0% | +15.2% | +62.2% | -11.5% | - |
| EBITDA growth | +7.7% | -24.6% | +29.3% | +18.0% | +34.1% | +5.5% | - |
| PBT growth | +8.6% | -56.5% | +25.6% | +28.9% | +43.8% | -2.9% | +12.5% |
| Net income growth | +305.9% | -115.0% | +19.2% | +18.7% | +29.7% | +59.1% | - |
| Revenue CAGR (3Y) | +12.4% | +15.9% | +29.4% | +18.3% | +14.8% | +4.5% | +14.6% |
| EBITDA CAGR (3Y) | +1.6% | +4.8% | +26.9% | +18.6% | +12.0% | +3.4% | +5.0% |
| Profitability & leverage | |||||||
| Net income margin | +3.0% | +0.2% | +8.9% | +8.4% | +7.7% | +9.8% | +5.7% |
| Return on capital employed | +6.1% | +6.1% | +11.6% | +10.3% | +8.9% | +6.7% | +7.4% |
| Return on net worth | +2.2% | -1.6% | +8.7% | +7.5% | +6.3% | +5.2% | +3.5% |
| Debt / equity | 0.54 | 0.43 | 0.29 | 0.19 | 0.12 | 0.07 | 0.08 |
| Long-term debt / equity | 0.19 | 0.20 | 0.17 | 0.10 | 0.07 | 0.05 | 0.07 |
| Interest cover | 55.05 | 59.21 | 13.94 | 11.72 | 10.14 | 8.98 | 15.85 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 0.81 | 0.83 | 0.85 | 0.91 | 0.84 | 0.54 | 0.63 |
| Inventory turnover | 3.22 | 3.87 | 4.42 | 5.25 | 9.69 | 22.52 | 34.74 |
| Debtors turnover | 5.66 | 6.80 | 7.44 | 7.76 | 7.14 | 4.55 | 5.53 |
| EPS (βΉ) | 3.48 | 0.58 | 7.83 | 6.31 | 5.01 | 3.93 | 2.55 |
| Dividend per share (βΉ) | 0.00 | 0.00 | 1.20 | 1.20 | 1.00 | 1.00 | 0.50 |
| Book value per share (βΉ) | 93.49 | 92.31 | 93.13 | 86.45 | 81.13 | 77.28 | 74.00 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 245 | 254 | 225 | 214 | 224 | 237 | 207 | 221 |
| Revenue growth (YoY) | +9.5% | +7.2% | +8.6% | -3.2% | +5.5% | +1.7% | - | - |
| Other income | 5.29 | 5.28 | 5.59 | 7.51 | 5.81 | 5.52 | 7.19 | 6.28 |
| Total expenses | 205 | 211 | 194 | 186 | 185 | 190 | 176 | 178 |
| EBITDA | 40.40 | 42.49 | 30.76 | 27.91 | 38.97 | 46.84 | 30.77 | 42.53 |
| EBITDA margin | +16.5% | +16.7% | +13.7% | +13.1% | +17.4% | +19.8% | +14.9% | +19.3% |
| Depreciation | 10.95 | 10.80 | 10.53 | 10.00 | 9.94 | 9.68 | 9.63 | 9.94 |
| Interest | 3.19 | 3.08 | 2.36 | 3.55 | 4.28 | 2.58 | 2.66 | 3.09 |
| Profit before tax | 31.55 | 33.89 | 23.46 | 21.87 | 30.56 | 40.10 | 25.67 | 35.78 |
| Tax | 8.05 | 8.82 | (30.21) | 8.09 | 10.81 | 14.41 | 10.72 | 14.91 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 899 | 869 | 830 | 708 | 647 | 419 | 484 |
| Revenue growth | +3.4% | +4.7% | +17.2% | +9.5% | +54.5% | -13.5% | - |
| Other income | 24.86 | 30.27 | 20.70 | 19.57 | 13.00 | 9.62 | 17.74 |
| Total expenses | 753 | 712 | 651 | 565 | 520 | 332 | 401 |
| Employee cost | 112 | 109 | 98.05 | 86.76 | 78.32 | 55.74 | 65.25 |
| EBITDA | 146 | 157 | 179 | 143 | 127 | 87.03 | 82.54 |
| EBITDA margin | +16.2% | +18.1% | +21.6% | +20.2% | +19.6% | +20.8% | +17.1% |
| Depreciation | 40.15 | 38.89 | 37.08 | 37.06 | 35.50 | 36.67 | 35.86 |
| Interest | 14.48 | 12.66 | 4.32 | 4.44 | 4.40 | 4.50 | 7.41 |
| Profit before tax | 116 | 136 | 158 | 121 | 99.92 | 55.48 | 57.01 |
| Tax | 3.09 | 51.95 | 54.47 | 40.55 | 30.11 | 12.61 | 29.06 |
| Net profit | 108 | 72.56 | 98.77 | 79.61 | 71.95 | 43.34 | 27.53 |
| Net profit margin | +12.0% | +8.4% | +11.9% | +11.2% | +11.1% | +10.4% | +5.7% |
| EPS (βΉ) | 10.50 | 7.80 | 9.67 | 7.53 | 6.46 | 3.97 | 2.59 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 108 | 107 | 107 | 107 | 108 | 108 | 108 |
| Reserves & surplus | 1,139 | 1,027 | 955 | 863 | 799 | 742 | 706 |
| Shareholders' funds (net worth) | 1,247 | 1,134 | 1,062 | 970 | 907 | 850 | 814 |
| Secured loans | 120 | 103 | 114 | 25.50 | 41.31 | 44.03 | 48.67 |
| Unsecured loans | 11.72 | 6.67 | 7.46 | 8.58 | 0.00 | 0.00 | 13.54 |
| Total debt | 131 | 110 | 121 | 34.08 | 41.31 | 44.03 | 62.21 |
| Total liabilities | 1,392 | 1,256 | 1,196 | 1,016 | 970 | 915 | 894 |
| Assets | |||||||
| Gross block | 950 | 868 | 851 | 817 | 806 | 802 | 779 |
| Net block | 621 | 579 | 599 | 603 | 628 | 658 | 670 |
| Capital work in progress | 0.26 | 8.04 | 5.24 | 10.05 | 5.74 | 7.52 | 6.39 |
| Investments | 623 | 599 | 511 | 313 | 62.09 | 32.10 | 42.75 |
| Inventories | 24.66 | 20.25 | 19.20 | 19.62 | 19.83 | 19.94 | 14.76 |
| Sundry debtors | 180 | 132 | 118 | 89.64 | 94.30 | 93.00 | 91.49 |
| Cash & bank balances | 13.39 | 21.66 | 9.23 | 3.32 | 104 | 82.97 | 28.71 |
| Loans & advances | 88.17 | 58.61 | 56.76 | 64.17 | 113 | 60.98 | 73.59 |
| Total current assets | 306 | 232 | 203 | 177 | 332 | 257 | 209 |
| Total current liabilities | 128 | 103 | 97.72 | 94.72 | 81.33 | 73.83 | 69.71 |
| Net working capital | 178 | 129 | 105 | 82.03 | 250 | 183 | 139 |
| Total assets | 1,392 | 1,256 | 1,196 | 1,016 | 970 | 915 | 894 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 21.60 | 9.20 | 3.29 | 49.39 | 6.02 | 8.44 | 5.12 |
| Net cash from operating activities | 91.19 | 149 | 140 | 165 | 101 | 77.24 | 57.09 |
| Net cash from investing activities | (109) | (101) | (206) | (172) | (40.32) | (51.83) | (32.28) |
| Net cash from financing activities | 9.16 | (35.80) | 72.14 | (38.21) | (17.25) | (27.82) | (21.50) |
| Net change in cash | (8.25) | 12.40 | 5.91 | (46.09) | 43.36 | (2.41) | 3.31 |
| Closing cash | 13.39 | 21.66 | 9.23 | 3.32 | 104 | 82.97 | 28.71 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +3.4% | +4.7% | +17.2% | +9.5% | +54.5% | -13.5% | - |
| EBITDA growth | -7.2% | -12.3% | +24.9% | +13.0% | +45.7% | +5.4% | - |
| PBT growth | -14.5% | -14.3% | +30.4% | +21.5% | +80.1% | -2.7% | +12.4% |
| Net income growth | +49.0% | -26.5% | +24.1% | +10.7% | +66.0% | +57.4% | - |
| Revenue CAGR (3Y) | +8.3% | +10.3% | +25.6% | +13.5% | +11.8% | +3.3% | +14.5% |
| EBITDA CAGR (3Y) | +0.6% | +7.4% | +27.2% | +20.2% | +14.9% | +2.9% | +4.4% |
| Profitability & leverage | |||||||
| Net income margin | +12.6% | +9.6% | +12.5% | +11.4% | +10.8% | +10.2% | +5.8% |
| Return on capital employed | +9.9% | +12.1% | +14.7% | +12.7% | +11.1% | +6.6% | +7.3% |
| Return on net worth | +9.5% | +7.6% | +10.2% | +8.6% | +8.0% | +5.2% | +3.5% |
| Debt / equity | 0.10 | 0.11 | 0.08 | 0.04 | 0.05 | 0.06 | 0.08 |
| Long-term debt / equity | 0.08 | 0.09 | 0.06 | 0.03 | 0.03 | 0.05 | 0.07 |
| Interest cover | 13.71 | 10.72 | 3.04 | 4.18 | 4.82 | 8.94 | 15.87 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 0.99 | 1.01 | 1.00 | 0.87 | 0.80 | 0.53 | 0.63 |
| Inventory turnover | 40.02 | 44.05 | 42.74 | 35.89 | 32.53 | 24.13 | 35.32 |
| Debtors turnover | 5.77 | 6.97 | 8.00 | 7.70 | 6.91 | 4.54 | 5.60 |
| EPS (βΉ) | 10.50 | 7.80 | 9.67 | 7.53 | 6.46 | 3.97 | 2.59 |
| Dividend per share (βΉ) | 0.00 | 0.00 | 1.20 | 1.20 | 1.00 | 1.00 | 0.50 |
| Book value per share (βΉ) | 115.97 | 105.50 | 98.89 | 90.42 | 83.95 | 78.66 | 75.34 |
Investments & Acquisitions by Shalby Hospitals
Shalby Hospitals has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Sanar International Hospitals and Slaney Healthcare.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Specialized healthcare services are provided in cancer care and orthopedics. | sanarhospitals.com | Gurugram, India | 2018 | Jan 2024 | β’β’β’β’ | |
Surgical instruments are manufactured by Slaney Healthcare in India. | slaneyhealthcare.com | Ahmedabad, India | 2010 | Sep 2020 | $9.7M |
Complete acquisition details for Shalby Hospitals
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Shalby Hospitals
4 dated milestones of Shalby Hospitals across 30 years, from founding to its latest funding, stage changes and deals.
- Founded Shalby Hospitals is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Slaney Healthcare.
- Acquisition Acquires Sanar International Hospitals.
Similar companies to Shalby Hospitals
Shalby Hospitals has 3 listed similar companies in our database, 2 of them funded. They include Fortis Healthcare, Ujala Cygnus and Narayana Health.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| fortishealthcare.com | 1996 | Gurugram, India | 1,565 | Multi-specialty hospital services are provided across India by Fortis Healthcare. | ||
| ujalacygnus.com | 2011 | Delhi, India | $36.74M | 2,084 | A chain of multi-specialty hospitals is operated in India. | |
| narayanahealth.org | 2000 | Bengaluru, India | $148.2M | 8,145 | A chain of multi-specialty hospitals is operated in India. |
Detailed similar companies of Shalby Hospitals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Shalby Hospitals
The website of Shalby Hospitals (shalby.org) receives about 36K visits a month.
- Monthly visits36K
▲ 19.8% vs previous month
Websites whose visitors overlap most with Shalby Hospitals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| kiranhospital.com | 100% | 16.7K | #1,559,287 | View details | |
| cims.org | 98% | 25.6K | #1,196,851 | View details | |
| zydushospitals.com | 97% | 65.2K | #508,541 | View details | |
| mgmch.org | 97% | 17.6K | #1,398,024 | View details | |
| hcghospitals.in | 97% | 27.3K | #857,509 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for Shalby Hospitals
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Hospitals & Clinical Care
3 companies that operate in the same segment as Shalby Hospitals (Hospitals & Clinical Care) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Maternity, childcare, and fertility services are delivered via hospital chains. | 2007 | Bengaluru, Karnataka, India | USD 204.87 M | USD 140.46 M | 6,354 | |
Chain of oncology hospitals | 1989 | Bengaluru, Karnataka, India | USD 36.59 M | USD 270.51 M | 321 | |
Chain of multi-super specialty healthcare hospitals | 2004 | Gurugram, Haryana, India | USD 104.7 M | USD 461.72 M | 12,240 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Shalby Hospitals
Complete news archive for Shalby Hospitals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shalby Hospitals
Shalby Hospitals was founded in 1994.
Shalby Hospitals is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
Ravi Bhandari is the CEO of Shalby Hospitals, as recorded in our data.
Shalby Hospitals has 2,497 employees.
The primary company behind Shalby Hospitals, Shalby Limited, reported revenue of βΉ1,168 Cr for FY 2026, up 5% year on year.
Shalby Hospitals was established in 1994 in Ahmedabad, India, as a chain of multi-specialty facilities. Healthcare services across various specialties are provided by the organization, with operations centered in India. The network focuses on medical treatments and patient care in urban and regional areas. Leadership is held by founder Vikram Shah and CEO Ravi Bhandari, supporting expansion in the healthcare sector.
Shalby Hospitals's top competitors include Fortis Healthcare, Ujala Cygnus and Narayana Health.
Yes, Shalby Hospitals is publicly traded on NSE under the ticker symbol SHALBY.
Shalby Hospitals has made 2 acquisitions, including Sanar International Hospitals, and Slaney Healthcare.
Shalby Hospitals is associated with 6 legal entities: Shalby Limited, Vrundavan Shalby Hospitals Limited, Shalby Medtech Limited and others.
The legal entities of Shalby Hospitals currently have 16 directors, including Viral Bhalchandra Shah, Ravi Bhandari, Ronak Jain and others.
